Affiliation:
1. Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, LA 70112, USA
Abstract
There are high levels
of comorbidity between neuropsychiatric and
cardiovascular disorders. A key molecule central
to both cognitive and cardiovascular function is
the molecule serotonin. In the brain, serotonin
modulates neuronal activity and is actively
involved in mediating many cognitive functions
and behaviors. In the periphery, serotonin is
involved in vasoconstriction, inflammation, and
cell growth, among other processes.
It is hypothesized that one component of the serotonin system, the
receptor, is a common and contributing factor underlying aspects of the comorbidity between neuropsychiatric and cardiovascular disorders.
Within the brain this receptor participates in processes such as cognition and working memory, been implicated in effective disorders such as schizophrenia, and mediate the primary effects of hallucinogenic drugs. In the periphery, receptors have been linked to vasoconstriction and hypertension, and to inflammatory processes that can lead to atherosclerosis.
Subject
Psychiatry and Mental health,Cardiology and Cardiovascular Medicine,Neurology (clinical),Neurology
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献